Webinar: Challenges for Oncology Trials in the Age of Personalized Medicine
Jun 11, 2015
We hear a lot about ‘personalised medicine’, but in oncology what does this really mean for clinical research? Dr. Tobias Arkenau and Matthew Simmons from Sarah Cannon Research Institute UK will look at cutting edge developments in technology and trial design, and how these have affected trial sites. The discussion will also consider how recent EU regulatory changes have created challenges and opportunities for sites, and finally will take a future-facing view of what advances are being made in patient identification to support smart development of personalised medicine in the years to come.